NCT04298892 2024-07-01
INTHEMA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Unknown
Clinical Trials
13 trialsNCT05983536 2023-08-09
The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)
Qianfoshan Hospital
Unknown
NCT05147493 2022-03-29
A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment
Hellenic Society of Hematology
Phase 2 Unknown
NCT05298683 2022-03-28
A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor
Hellenic Society of Hematology
Phase 2 Unknown
NCT04720144 2021-02-09
BIMI
Centre Hospitalier Universitaire Vaudois
Unknown
NCT02380378 2019-04-02
MPN
Hospital Israelita Albert Einstein
Unknown
NCT03868527 2019-03-11
Arcan database
Hospices Civils de Lyon
Unknown
NCT03272789 2019-01-23
REBOND
Institut Paoli-Calmettes
Phase NA Unknown
NCT03556748 2018-06-14
WB-EMS and Nutrition in Patients With Hematological Malignancies
University of Erlangen-Nürnberg Medical School
Phase NA Unknown
NCT02806791 2016-06-21
Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment
Azienda Ospedaliera San Giovanni Battista
Unknown
NCT02456818 2016-02-08
CONTAIN
University of Cologne
Unknown
NCT00866762 2011-12-12
A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia
Copenhagen University Hospital at Herlev
Phase 2 Unknown
NCT00883961 2009-12-23
Exercise Following Autologous Peripheral Blood Stem Cell Transplantation
Charite University, Berlin, Germany
Phase 3 Unknown